Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Inherited BRCA2 mutation associated with high grade breast cancer

By Agnarsson B.A.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 2, 1998-01 ,pp. : 121-127

Springer Publishing Company

Access to resources Recommend Favorite

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

By Pierce Lori  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 389-398

Springer Publishing Company

Access to resources Recommend Favorite

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

By Einbeigi Z.   Bergman A.   Kindblom L.-G.   Martinsson T.   Meis-Kindblom J.M.   Nordling M.   Suurkula M.   Wahlstrom J.   Wallgren A.   Karlsson P.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1904-1909

Elsevier

Access to resources Recommend Favorite

BRCA1 as Target for Breast Cancer Prevention and Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 4-14

Bentham Science Publishers

Access to resources Recommend Favorite